These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 81557)

  • 1. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 2. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 3. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 4. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 5. Encephalitogenic epitopes of myelin basic protein.
    Fritz RB; McFarlin DE
    Chem Immunol; 1989; 46():101-25. PubMed ID: 2482036
    [No Abstract]   [Full Text] [Related]  

  • 6. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental allergic encephalomyelitis: immunological properties of encephalitogenic polypeptides and proteins.
    Lamoureux G; Carnegie PR; McPherson TA; Johnston D
    Clin Exp Immunol; 1967 Sep; 2(5):601-9. PubMed ID: 4965043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
    Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
    Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
    J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination.
    Wisniewski HM; Schuller-Levis GB; Mehta PD; Madrid RE; Lassmann H
    Concepts Immunopathol; 1985; 2():128-50. PubMed ID: 2439203
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin basic protein, a specific protein of the central nervous system.
    Karcher D
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():85-7. PubMed ID: 6202352
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-way cross-reaction between spinal cord protein and myelin basic protein.
    MacPherson CF; Prokopchuk P; Ramshaw IA; Ziola B
    Prog Clin Biol Res; 1984; 146():265-70. PubMed ID: 6201898
    [No Abstract]   [Full Text] [Related]  

  • 19. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.